Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
N05AD01	HALDOL	B	Haloperidol - 5mg	5mg	Tablet	231,141 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 5mg	5mg	Tablet	276,448 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 2mg	2mg	Tablet	252,130 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 20mg	20mg	Tablet	339,160 L.L
N05AD01	HALOPERIDOL	G	Haloperidol - 10mg	10mg	Tablet	339,160 L.L
N05AD01	HALDOL DECANOAS	B	Haloperidol (Decanoate) - 50mg/ml	50mg/ml	Injectable solution	444,812 L.L
L01BC05	HAXANIT	G	Gemcitabine (HCl) - 200mg	200mg	Injectable lyophilised powder	1,411,035 L.L
L01BC05	HAXANIT	G	Gemcitabine (HCl) - 1g	1g	Injectable lyophilised powder	6,829,408 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 2g	2g	Injectable powder for solution	75,608,610 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	37,803,732 L.L
B03XA01	HEMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 40,000IU	40,000IU	Injectable freeze dried powder + diluent	6,316,060 L.L
B03XA01	HEMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU	4,000IU	Injectable freeze dried substance+diluent	940,690 L.L
B03XA01	HEMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU	4,000IU	Injectable freeze dried substance+diluent	33,852,747 L.L
B03XA01	HEMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 20,000IU	20,000IU	Injectable freeze dried powder + diluent	5,438,531 L.L
B03XA01	HEMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 10,000IU	10,000IU	Injectable freeze dried substance+diluent	2,490,140 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	36,052,162 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	L.L
C03DA04	HEPERONA 50	G	Eplerenone - 50mg	50mg	Tablet, coated	2,150,148 L.L
C03DA04	HEPERONA 25	G	Eplerenone - 25mg	25mg	Tablet, coated	2,116,552 L.L
J05AF10	HEPCAVIR 1	G	Entecavir monohydrate - 1mg	1mg	Tablet, film coated	18,998,515 L.L
J05AF10	HEPCAVIR 0.5	G	Entecavir monohydrate - 0.5mg	0.5mg	Tablet, film coated	18,998,515 L.L
B01AB05	HEPAXANE 4000IU	BioTech	Enoxaparin sodium - 40mg/0.4ml	40mg/0.4ml	Injectable solution	4,063,780 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 60mg/0.4ml	60mg/0.4ml	Injectable solution	441,042,377 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	224,585,721 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 150mg/ml	150mg/ml	Injectable solution	716,437,779 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 105mg/0.7ml	105mg/0.7ml	Injectable solution	577,741,643 L.L
R05CA12	HEDECTON COUGH	G	Dried Ivy leaf extract - 40mg/5ml		Syrup	467,657 L.L
R05CA12	HEDERAL		Dried Ivy leaf extract - 37mg/5ml			309,084 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg		Injectable suspension	4,462,901 L.L